|  |  |  | | | | | RegenMD | | | | | | | | | | | | | | | | | | Years ago, the notion of regenerative medicine was something that only happened in fairy tales, but Cytori Therapeutics released ground breaking data showing a significant improvement in heart functioning at the annual meeting of The American Heart ...
See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | | | | Advanced BioHealing Inc. unveiled plans to offer up to $200 million in shares in an initial public offering, as the regenerative medicine company aims to raise funds for working capital and other purposes, including a second manufacturing plant. ...
See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | | | | TiGenix is exploring the use of regenerative medicine to develop local treatments for damaged and osteoarthritic joints, according to its website. Its lead commercial product is ChondroCelect for cartilage regeneration in the knee. ...
See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | | | | Commenting on the Company's performance, Chane Graziano, CEO, stated, "2010 was a landmark year for HBIO, with the development of our new Regenerative Medicine Device business. Therefore, we will now be reporting on two business units. ...
See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | | | | BR) plans to merge operations with Spanish peer Cellerix and raise 15 million euros ($20.69 million) in a rights issue to expand further into regenerative medicine. TiGenix said in a statement on Friday it had agreed to combine operations though a ...
See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | | | | | Do patients with complete transposition of the great arteries and severe pulmonary hypertension benefit from an arterial switch operation? Ann Thorac Surg. 2011 Jan;91(1):181-6 Authors: Fan H, Hu S, Zheng Z, Li S, Zhang Y, Pan X, Liu Y Whether an arterial switch operation benefits patients with transposition of the great arteries and severe pulmonary hypertension (PH) remains controversial. Therefore, we evaluated the relationship between preoperative PH and early and midterm clinical outcomes after an arterial switch procedure. PMID: 21172509 [PubMed - indexed for MEDLINE] | | | | | | | | | | | | | | | | | | | | | | | | | Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg. 2011 Jan;127 Suppl 1:75S-90S Authors: Lazic T, Falanga V Over the past two decades, the field of wound healing and tissue repair has witnessed tremendous advances resulting from the biological sciences, biomedical and tissue engineering, and greater clinical understanding of wounds and their pathophysiology. In large part because of these advances, clinicians are now able to offer and deliver more sophisticated and effective treatments to patients with acute wounds, chronic wounds, burns, and other types of injuries. PMID: 21200276 [PubMed - indexed for MEDLINE] | | | | | | | | | | | | | | | | | | | | | | | | | The role of stem cells in cutaneous wound healing: what do we really know? Plast Reconstr Surg. 2011 Jan;127 Suppl 1:10S-20S Authors: Ko SH, Nauta A, Wong V, Glotzbach J, Gurtner GC, Longaker MT Wound repair is a complex process involving the orchestrated interaction of multiple growth factors, cytokines, chemokines, and cell types. Dysregulation of this process leads to problems such as excessive healing in the form of keloids and hypertrophic scars and chronic, nonhealing wounds. These issues have broad global implications. Stem cells offer enormous potential for enhancing tissue repair and regeneration following injury. The rapidly developing fields of stem cell biology and skin tissue engineering create translational opportunities for the development of novel stem cell-based wound-healing therapies. PMID: 21200267 [PubMed - indexed for MEDLINE] | | | | | | | | | |  | |  | |  |
No comments:
Post a Comment